Precision medicine in rheumatoid arthritis

Date: 15:00-16:30, Wednesday 19 May

Title: Precision medicine in rheumatoid arthritis

CPD: 1 credit

Audience: entire multidisciplinary team

Host: Centre for Genetics and Genomics and Centre for Epidemiology

Speakers: Prof Anne Barton (professor of rheumatology), Dr Suzanne Verstappen (epidemiologist), Sarah Wood (pharmacist), Dr James Bluett (senior clinical lecturer and honorary consultant rheumatologist)

Topics:

Precision medicine aims to identify factors that allow the targeting of the right drugs to the right patients. This webinar highlights progress and challenges in this area, including practical insights for rheumatologists to consider when prescribing DMARDs. Topics include:

• Overview of area of research focussing on assessing response to treatment – Prof Anne Barton

• Latest developments: predictors of adherence to methotrexate – Dr Suzanne Verstappen

• Latest developments: the pharmacy perspective – Sarah Wood

• Translating to patient benefit: key lessons and implementation – Dr James Bluett

• Recent developments and research in the field

Learning objectives

• To understand strengths and limitations of current measures of treatment response, focusing on DAS28 scores

• To update knowledge on what is known about predictors of adherence

• To learn about the role of the community pharmacist in advising on treatments

• To learn how research findings can be used to implement service changes and improve patient outcomes